Section of Paediatric Infectious Disease, Department of Infectious Disease, Imperial College London, London, UK.
Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Eur J Hum Genet. 2021 Dec;29(12):1734-1744. doi: 10.1038/s41431-021-00838-5. Epub 2021 Mar 26.
Kawasaki disease (KD) is a paediatric vasculitis associated with coronary artery aneurysms (CAA). Genetic variants influencing susceptibility to KD have been previously identified, but no risk alleles have been validated that influence CAA formation. We conducted a genome-wide association study (GWAS) for CAA in KD patients of European descent with 200 cases and 276 controls. A second GWAS for susceptibility pooled KD cases with healthy paediatric controls from vaccine trials in the UK (n = 1609). Logistic regression mixed models were used for both GWASs. The susceptibility GWAS was meta-analysed with 400 KD cases and 6101 controls from a previous European GWAS, these results were further meta-analysed with Japanese GWASs at two putative loci. The CAA GWAS identified an intergenic region of chromosome 20q13 with multiple SNVs showing genome-wide significance. The risk allele of the most associated SNV (rs6017006) was present in 13% of cases and 4% of controls; in East Asian 1000 Genomes data, the allele was absent or rare. Susceptibility GWAS with meta-analysis with previously published European data identified two previously associated loci (ITPKC and FCGR2A). Further meta-analysis with Japanese GWAS summary data from the CASP3 and FAM167A genomic regions validated these loci in Europeans showing consistent effects of the top SNVs in both populations. We identified a novel locus for CAA in KD patients of European descent. The results suggest that different genes determine susceptibility to KD and development of CAA and future work should focus on the function of the intergenic region on chromosome 20q13.
川崎病(KD)是一种与冠状动脉瘤(CAA)相关的儿科血管炎。先前已经确定了影响 KD 易感性的遗传变异,但尚未验证影响 CAA 形成的风险等位基因。我们对欧洲血统的 KD 患者进行了全基因组关联研究(GWAS),以研究 CAA,病例组有 200 例,对照组有 276 例。第二项 GWAS 对英国疫苗试验中的 KD 病例与健康儿科对照者的易感性进行了汇总(n=1609)。这两项 GWAS 均使用逻辑回归混合模型进行分析。对先前欧洲 GWAS 的 400 例 KD 病例和 6101 例对照者进行了易感性 GWAS 荟萃分析,这些结果与来自日本的 GWAS 荟萃分析在两个假定的基因座上进行了进一步分析。CAA GWAS 确定了染色体 20q13 上的一个基因间区域,该区域有多个 SNV 达到全基因组显著水平。最相关 SNV(rs6017006)的风险等位基因存在于 13%的病例和 4%的对照者中;在东亚 1000 基因组数据中,该等位基因缺失或罕见。与先前发表的欧洲数据进行荟萃分析的易感性 GWAS 确定了两个先前相关的基因座(ITPKC 和 FCGR2A)。与来自 CASP3 和 FAM167A 基因组区域的日本 GWAS 汇总数据的进一步荟萃分析在欧洲人身上验证了这些基因座,表明两个人群中最高 SNV 的效应一致。我们确定了欧洲裔 KD 患者中 CAA 的一个新基因座。结果表明,不同的基因决定了 KD 的易感性和 CAA 的发展,未来的工作应集中在染色体 20q13 上的基因间区域的功能上。